Geron Corporation Is A Biotechnology Company Located In Foster Citycaliforniafounded In 1990It Specializes In Developing And Commercializing Therapeutic Products For Cancerwith A Particular Emphasis On Telomerase Inhibitorsthe Company Is Publicly Traded On The Nasdaq Under The Ticker Symbol Gern And Is Part Of The Russell 2000 Index Geron S Main Product Is Imetelstata Telomerase Inhibitor Currently In Phase 3 Clinical Trialsthis Treatment Targets The Uncontrolled Proliferation Of Malignant Stem And Progenitor Cells In Specific Blood Cancersincluding Low Or Intermediate 1 Risk Myelodysplastic Syndromes And Intermediate 2 Or High Risk Myelofibrosisanother Productrytelois Also A Telomerase Inhibitoralthough Details About Its Development Stage Are Less Cleargeron S Products Are Intended For Use In Medical Settingswhere Healthcare Professionals Can Prescribe Them To Patients With Specific Types Of Blood Cancersthe Company Employs Around 229 Full Time Staff And Is Committed To Addressing Significant Unmet Medical Needs In Oncology
